Glenmark wins U.S. approval for mometasone, metformin doses

05/30/2008 | Business Standard (India)

Glenmark Pharmaceuticals unit Glenmark Generics has secured final approval from the FDA for new strengths of mometasone furoate topical treatments, as well as new dosages of metformin hydrochloride tablets -- the generic version of Bristol-Myers Squibb Co.'s diabetes drug Glucophage. The products will be launched in the U.S. soon, the Indian drug firm said.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY